Afya Limited IPO Advisory
Share this IPO Profile:Smart Search
For IPO Boutique's "scale of 1 to 5" BUY rating on Afya Limited, and our comprehensive analysis, click "Buy Market Research".
Company |
Symbol |
Price Range |
Issue Price |
Open |
Shares |
Trade Date |
| Afya Limited | AFYA - NASDAQ |
$16.00-$18.00 | $19.00 | $23.50 | 13.7 million | 7/19/2019 |
| BofA Merrill Lynch, Goldman Sachs, UBS Investment Bank, Itau BBA, Morgan Stanley, BTG Pactual, XP Investments | ||||||
Co-Manager(s): | ||||||
| Consumer | ||||||
Filing(s): Filed 2019-06-24 Terms Added 2019-07-09 | ||||||
Afya Limited Quote & Chart - Click for current quote - AFYA
IPO Boutique aggregates information on public companies and private companies, such as "AFYA" IPO, which is intended to educate our readers and help them evaluate potential investment opportunities and market conditions. We endeavor to research the financial industry and obtain independent verification of factual statements before presenting them to our users. Be informed.
About Afya Limited (adapted from Afya Limited prospectus):
They are the leading medical education group in Brazil based on number of medical school seats, as published by the Brazilian Ministry of Education
This description is adapted from prospectus. This description is not intended to be a recommendation to buy stock from this company. To see the company's full description, view their prospectus.
They are the leading medical education group in Brazil based on number of medical school seats, as published by the Brazilian Ministry of Education
This description is adapted from prospectus. This description is not intended to be a recommendation to buy stock from this company. To see the company's full description, view their prospectus.
IPO Boutique aggregates information on public companies and private companies, such as "AFYA" IPO, which is intended to educate our readers and help them evaluate potential investment opportunities and market conditions. We endeavor to research the financial industry and obtain independent verification of factual statements before presenting them to our users. Be informed.